{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:10:32Z","timestamp":1772518232134,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report cases of central retinal vein occlusion in otherwise healthy children showing combined genetic variants of thrombophilia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Ophthalmological, pediatric records and genetic analyses of thrombophilia-associated variants were retrospectively reviewed in four children diagnosed with central retinal vein occlusion. Genetic screening, including <jats:italic toggle=\"yes\">Factor XII<\/jats:italic>, <jats:italic toggle=\"yes\">platelet glycoprotein (GP) IIIa PlA1\/A2 (rs5918)<\/jats:italic>, and <jats:italic toggle=\"yes\">GPIa\/IIa C807T (rs1126643)<\/jats:italic> and <jats:italic toggle=\"yes\">G873A (rs1062535)<\/jats:italic> mutations, was performed by PCR amplification and Sanger sequencing of PCR products. The genotyping of <jats:italic toggle=\"yes\">prothrombin G20210A<\/jats:italic>, <jats:italic toggle=\"yes\">Leiden Factor V G1691A, methylenetetrahydrofolate reductase (MTHFR) C677T\/A1298C<\/jats:italic> mutations, and <jats:italic toggle=\"yes\">plasminogen activator inhibitor-1 4G\/5G<\/jats:italic> polymorphisms was performed by real-time PCR with Fluorescence Resonance Energy Transfer (FRET) probes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The genotyping analysis identified combined genetic variants of thrombophilia in each patient. Mutations for <jats:italic toggle=\"yes\">MTHFR (C677T)<\/jats:italic> and <jats:italic toggle=\"yes\">GPIIIa PlA1\/A2<\/jats:italic> were detected in Case 1, mutations for <jats:italic toggle=\"yes\">MTHFR (C677T)<\/jats:italic>, <jats:italic toggle=\"yes\">GPIIIa PlA1\/A2<\/jats:italic>, and <jats:italic toggle=\"yes\">GPIa\/IIa<\/jats:italic> in Case 2, mutations for <jats:italic toggle=\"yes\">MTHFR (C677T)<\/jats:italic> and <jats:italic toggle=\"yes\">GPIa\/IIa<\/jats:italic> in Case 3, and mutation for <jats:italic toggle=\"yes\">MTHFR (A12986C)<\/jats:italic>, <jats:italic toggle=\"yes\">GPIIIa Pl A1\/A2<\/jats:italic>, and <jats:italic toggle=\"yes\">GPIa\/IIa<\/jats:italic> in Case 4. Preventive low-dose aspirin therapy was prescribed to all patients. During a follow-up of 5 and 8 years, neither central retinal vein occlusion recurrence nor any other thrombotic event was observed in Cases 1 and 2, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In otherwise healthy children presenting central retinal vein occlusion, genetic investigations for thrombophilia-associated variants should be considered, given the possible long-term benefit of aspirin prophylaxis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002563","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T21:42:08Z","timestamp":1557870128000},"page":"1339-1343","source":"Crossref","is-referenced-by-count":8,"title":["CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS"],"prefix":"10.1097","volume":"40","author":[{"given":"Dominique","family":"Bremond-Gignac","sequence":"first","affiliation":[{"name":"Ophthalmology Department, University Hospital Necker Enfants-Malades, APHP, Paris, France;"},{"name":"CNRS FR3636, Universit\u00e9 Paris V Descartes, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Daruich","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, University Hospital Necker Enfants-Malades, APHP, Paris, France;"},{"name":"INSERM, UMRS1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Centre de Recherche des Cordeliers, Universit\u00e9 Paris Descartes Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marl\u00e8ne","family":"Gallet","sequence":"additional","affiliation":[{"name":"Reproductive Biology and Cytogenetics, University Hospital and School of Medicine, Picardie University Jules Verne, Amiens, France;"},{"name":"PERITOX Laboratory, CURS, Jules Verne University of Picardie, Amiens, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Alain","family":"Menoud","sequence":"additional","affiliation":[{"name":"Molecular Genetics Department, Unilabs, Lausanne, Switzerland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Nowomiejska","sequence":"additional","affiliation":[{"name":"Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Rejdak","sequence":"additional","affiliation":[{"name":"Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[{"name":"INSERM, UMRS1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Centre de Recherche des Cordeliers, Universit\u00e9 Paris Descartes Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moncef","family":"Benkhalifa","sequence":"additional","affiliation":[{"name":"Reproductive Biology and Cytogenetics, University Hospital and School of Medicine, Picardie University Jules Verne, Amiens, France;"},{"name":"PERITOX Laboratory, CURS, Jules Verne University of Picardie, Amiens, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Copin","sequence":"additional","affiliation":[{"name":"Reproductive Biology and Cytogenetics, University Hospital and School of Medicine, Picardie University Jules Verne, Amiens, France;"},{"name":"PERITOX Laboratory, CURS, Jules Verne University of Picardie, Amiens, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230817","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12982","article-title":"Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study","volume":"13","author":"Ponto","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R2-20230817","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11739-010-0478-2","article-title":"Retinal vein occlusions: a review for the internist","volume":"6","author":"Marcucci","year":"2011","journal-title":"Intern Emerg Med"},{"key":"R3-20230817","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/IAE.0000000000000366","article-title":"Thrombophilic risk factors are uncommon in young patients with retinal vein occlusion","volume":"35","author":"Ahluwalia","year":"2015","journal-title":"Retina"},{"key":"R4-20230817","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.eye.6700040","article-title":"Central retinal vein occlusion and thrombophilia","volume":"16","author":"Fegan","year":"2002","journal-title":"Eye (Lond)"},{"key":"R5-20230817","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.eye.6700452","article-title":"The platelet glycoprotein Ia\/IIa gene polymorphism C807T\/G873A: a novel risk factor for retinal vein occlusion","volume":"17","author":"Dodson","year":"2003","journal-title":"Eye (Lond)"},{"key":"R6-20230817","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-3848(99)00111-5","article-title":"The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion","volume":"96","author":"Larsson","year":"1999","journal-title":"Thromb Res"},{"key":"R7-20230817","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0047-6374(01)00307-4","article-title":"Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia","volume":"122","author":"Bottiglieri","year":"2001","journal-title":"Mech Ageing Dev"},{"key":"R8-20230817","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1076029609348644","article-title":"Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis","volume":"16","author":"Sottilotta","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"R9-20230817","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(01)00842-9","article-title":"Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age","volume":"109","author":"Lahey","year":"2002","journal-title":"Ophthalmology"},{"key":"R10-20230817","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/13816810.2016.1244694","article-title":"Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G\/5G and the risk of retinal vein occlusion","volume":"38","author":"Kuhli-Hattenbach","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"R11-20230817","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1160\/TH09-05-0331","article-title":"Coagulation disorders and the risk of retinal vein occlusion","volume":"103","author":"Kuhli-Hattenbach","year":"2010","journal-title":"Thromb Haemost"},{"key":"R12-20230817","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaapos.2012.04.006","article-title":"Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates","volume":"16","author":"Goel","year":"012","journal-title":"J AAPOS"},{"key":"R13-20230817","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3928\/01913913-20100719-11","article-title":"Branch retinal artery occlusion and non-ischemic central retinal vein occlusion due to hyperhomocysteinemia in a 14-year-old child","volume":"47","author":"Rosenbaum","year":"2010","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R14-20230817","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006246505126","article-title":"Combined central retinal artery and vein occlusion in a child with systemic non-Hodgkin's lymphoma","volume":"22","author":"Saatci","year":"1998","journal-title":"Int Ophthalmol"},{"key":"R15-20230817","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaapos.2006.09.007","article-title":"Central retinal venous occlusion in an otherwise-healthy child","volume":"11","author":"Al-Dhibi","year":"2007","journal-title":"J AAPOS"},{"key":"R16-20230817","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaapos.2015.04.012","article-title":"Central retinal vein occlusion in an otherwise healthy child treated successfully with a single injection of bevacizumab","volume":"19","author":"Zheng","year":"2015","journal-title":"J AAPOS"},{"key":"R17-20230817","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10384-007-0541-3","article-title":"Central retinal vein occlusion in an otherwise healthy child","volume":"52","author":"Lee","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"R18-20230817","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.ICB.0000279641.53583.66","article-title":"Methylenetetrahydrofolate reductase gene mutation in a 16-year-old girl with combined central retinal vein occlusion\/cilioretinal artery occlusion","volume":"1","author":"Scheufele","year":"2007","journal-title":"Retin Cases Brief Rep"},{"key":"R19-20230817","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH09-09-0626","article-title":"Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action","volume":"103","author":"Squizzato","year":"2010","journal-title":"Thromb Haemost"},{"key":"R20-20230817","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1160\/TH03-08-0509","article-title":"Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels","volume":"92","author":"Gori","year":"2004","journal-title":"Thromb Haemost"},{"key":"R21-20230817","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1076029616672584","article-title":"Association of polymorphisms in coagulation factor genes and enzymes of homocysteine metabolism with arterial ischemic stroke in children","volume":"23","author":"Coen Herak","year":"2017","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T01:13:36Z","timestamp":1692234816000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002563"}},"subtitle":["Association With Multigenetic Variants of Thrombophilia"],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002563","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}